Microcarcinoma of the thyroid gland the Gustave-Roussy Institute experience

Cancer

Volumn 83, Issue 3, 1998, Pages 553-559

  Baudin, Eric ^a   Travagli, Jean P ^a   Ropers, Jacques ^a   Mancusi, Francesco ^a   Bruno Bossio, Gabriella ^a   Caillou, Bernard ^a   Cailleux, Anne F ^a   Lumbroso, Jean D ^a   Parmentier, Claude ^a   Schlumberger, Martin ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Differentiated thyroid carcinoma; Iodine 131 radioiodine therapy; Multivariate analysis; Prognosis; Recurrence; Surgery; Thyroid microcarcinoma

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CHILD; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SUBTOTAL THYROIDECTOMY; THYROID CARCINOMA;

ADOLESCENT; ADULT; AGED; CARCINOMA; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; THYROID NEOPLASMS;

EID: 0007484542     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO;2-U     Document Type: Article

References (26)

1. Hedinger C, Williams ED, Sobin LH, editors. Histologic typing of thyroid tumours. In: International histological classification of tumours, No. 11. Geneva: World Health Organization, 1988:1-18.
2. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102: 1088-95.
3. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947-53.
4. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-24.
5. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
6. Sampson RJ, Key CR, Buncher CR, lijima S. Thyroid carcinoma in Hiroshima and Nagasaki: prevalence of thyroid carcinoma at autopsy. JAMA 1969;209:65-70.
7. Sampson RJ, Oka H, Key CR, Buncher CR, lijima S. Metastases from occult thyroid carcinoma: an autopsy study from Hiroshima and Nagasaki, Japan. Cancer 1970;25:803-11.
8. Fukunaga FH, Yatani R. Geographic pathology of occult thyroid carcinomas. Cancer 1975;36:1095-9.
9. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid: a "normal" finding in Finland. A systematic autopsy study. Cancer 1985;56:531-8.
10. Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid: evaluation of 1,020 sequential autopsies. Am J Clin Pathol 1988;90:72-6.
11. Edis AJ. Natural history of occult thyroid cancer. In: Radiation-associated thyroid carcinoma. DeGroot LJ, Frohman LA, Kaplan EL, Refetoff S, et al., editors. New York: Grune & Stratton, 1977:155-60.
12. Hazard JB. Small papillary carcinoma of the thyroid: a study with special reference to so-called nonencapsulated sclerosing tumor. Lab Invest 1960;9:86-97.
13. Hubert JP, Kiernan PD, Beahrs OH, McConahey WM, Woolner LB. Occult papillary carcinoma of the thyroid. Arch Surg 1980;115:394-8.
14. Rossi RL, Cady B, Silverman ML, Wool MS, Horner TA. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 1986;10:612-22.
15. Vickery AL, Wang CA, Walker AM. Treatment of intrathyroidal papillary carcinoma of the thyroid. Cancer 1987;60:2587-95.
16. Hay ID, Grant CS, Van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992;112: 1139-47.
17. Salvadori B, Del Bo R, Pilotti S, Grassi M, Cusumano F. "Occult" papillary carcinoma of the thyroid: a questionable entity. Eur Cancer 1993;29A:1817-20.
18. Mellière D. Petits nodules thyroïdiens et microcancers. Presse Med 1995;24:1552-4.
19. Strate SM, Lee EL, Childers JH. Occult papillary carcinoma of the thyroid with distant metastases. Cancer 1984;54:1093-100.
20. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794-804.
21. Schlumberger M, Challeton C, De Vathaire F, et al. Radio-active iodine treatment and external radiotherapy for lung and bone metastases from thyroid cancer. J Nucl Med 1996; 37:598-605.
22. Russel WO, Ibanez ML, Clark RL, Withe EC. Thyroid carcinoma: classification, intraglandular dissemination, and clinicopathological study based upon whole organ sections of 80 glands. Cancer 1963;16:1425-60.
23. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985;55:805-28.
24. Clark RL, White EC, Russel WO. Total thyroidectomy for cancer of the thyroid: significance of intraglandular dissemination. Ann Surg 1959;6:859-66.
25. Grebe SKG, Hay ID. Thyroid cancer nodal mestastases: biologic significance and therapeutic considerations. Surg Oncol Clin North Am 1996;5:43-63.
26. Tollefsen HR, Shah JP, Huvos AG. Papillary carcinoma of the thyroid. Am J Surg 1972;124:468-72.